SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Howe who wrote (2861)5/19/1999 9:58:00 PM
From: Bob Swift  Read Replies (2) of 10280
 
David,

I think sibutramine is Meridia.
What do you think the net income from Nori would be if SEPR were to market it on their own ? More sales force and advertisement needed but the market is going to be big if it works better than Claritin.
Secondly, from what Peter described, income from DCL may be considered secured. If NDA is filed in Q4 and assuming a 1 year lag in approval, we are looking at income starting Q4 next year. Does that change your projection ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News